Clinical trial
Prospective, Multi-country, Observational Registry to Collect Clinical Information on Patients With Endogenous Cushing's Syndrome to Assess Drug Utilization Pattern and to Document the Safety and Effectiveness of Ketoconazole.
NCT04872920 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-country, Observational Registry to Collect Clinical Information on Patients With Endogenous Cushing's Syndrome to Assess Drug Utilization Pattern and to Document the Safety and Effectiveness of Ketoconazole.
- Lead sponsor
- HRA Pharma
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 20, 2018
- Completion date
- March 1, 2024
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.